BioLargo Inc (OTCPK:BLGO)
$ 0.095 +0.0013 (+1.35%) Market Cap: 31.15 Mil Enterprise Value: 34.48 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q2 2024 BioLargo Inc Earnings Call Transcript

Aug 14, 2024 / 08:30PM GMT
Release Date Price: $0.2352 (-1.26%)

Key Points

Positve
  • BioLargo Inc (BLGO) reported record revenues for Q2 2024, achieving $5 million in revenue for the quarter and nearly $9.8 million for the first half of the year.
  • The company maintained strong gross profit margins, generating over $2 million in gross profits for the quarter.
  • BioLargo Inc (BLGO) has a positive cash flow from operations, producing $330,000 in positive cash flow for the first six months of 2024.
  • The company has a strong balance sheet with $4 million in working capital and $4.8 million in cash, positioning it well for future growth.
  • BioLargo Inc (BLGO) has secured significant partnerships and contracts, including new retail accounts for its Pooph product and engineering contracts with the Air Force, indicating expanding commercial opportunities.
Negative
  • Despite record revenues, BioLargo Inc (BLGO) reported net losses, although these were narrow and largely due to non-cash charges.
  • The adoption cycles for some of BioLargo Inc (BLGO)'s innovations are lengthy and can be frustrating, potentially delaying revenue realization.
  • The company faces high competition in the market, particularly for its Pooph product, which could impact its growth trajectory.
  • BioLargo Inc (BLGO) has been investing heavily in its subsidiaries, which has been financially taxing and could strain resources if not managed carefully.
  • The commercialization of certain technologies, such as Clyra Medical's products, has been slow, with significant time and investment required before seeing substantial returns.
Operator

Greetings. Welcome to the BioLargo second quarter 2024 earnings results conference call. At this time, all participants are in a listen-only mode. (Operator Instructions) Please note this conference is being recorded.

I will now hand the conference over to your host, Brian Loper. You may begin.

Brian Loper
Clearthink Capital LLC - Investor Relations

Great. Thank you, operator. Good afternoon, everybody, and welcome to BioLargo's Q1 2024 Earnings Results Conference Call for the month ended June 30, 2024. By now, everyone should have had access to the earnings press release, which was issued on August 6. This call is being webcast and available for replay.

In our remarks today, we will include statements that are considered forward-looking within the meanings of securities laws, including forward-looking statements about future results of operations, business strategies, and plans, our relationships with our customers, market and potential growth opportunities.

In addition, management may make additional forward-looking statements in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot